Effectiveness and Satisfaction With Brief Synchronous Tele-psychiatry Consult

Sponsor
Mayo Clinic (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02967835
Collaborator
(none)
0
1
1
4.4
0

Study Details

Study Description

Brief Summary

Will Tele-psychiatry be effective and acceptable to patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tele-psychiatry consult
N/A

Detailed Description

This pilot aims to provide tele-psychiatry consults to patients at regional Mayo Clinic Florida primary care sites. The primary aim of this study is to assess the impact of brief tele-psychiatry consults on depression and anxiety outcomes for patients enrolled in complex care management; the secondary aim is to assess patient satisfaction with brief tele-psychiatry consults.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot to Assess Effectiveness of and Satisfaction With Brief Synchronous Tele-psychiatry Consult
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Jun 14, 2017
Actual Study Completion Date :
Jun 14, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telepsychiatry Consult

One time tele-psychiatry consultation to provide treatment recommendations for patients primary care physician.

Behavioral: Tele-psychiatry consult
tele-psychiatry consult for evaluation and treatment recommendations

Outcome Measures

Primary Outcome Measures

  1. Depression Outcome [6 month]

    Will measure depression outcome by measuring PHQ9 score at baseline and 6 months after initial tele-psychiatry consult.

  2. Anxiety Outcome [6 month]

    Will measure Anxiety outcome by using GAD7 score at baseline and 6 months after initial tele-psychiatry consult.

Secondary Outcome Measures

  1. Patient satisfaction with tele-psychiatry consult [baseline visit]

    Assess patient satisfaction with tele-psychiatry consult at baseline visit by use of patient satisfaction questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  1. Enrolled in complex care management

  2. PHQ9 above 10 or GAD7 above 10.

Exclusion Criteria

  1. Not able to provide informed consent

  2. Severe cognitive impairments or sensory deficits

  3. Not able to understand and speak English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic in Florida Jacksonville Florida United States 32224

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Mohit Chauhan, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohit Chauhan, M.B.B.S., Senior Associate Consultant, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT02967835
Other Study ID Numbers:
  • 16-003068
First Posted:
Nov 18, 2016
Last Update Posted:
Feb 7, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 7, 2019